Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct;205(4):1288-1290.
doi: 10.1111/bjh.19723. Epub 2024 Aug 28.

TTP and pregnancy

P Gounder  1 , M Scully  1   2
Affiliations
Review

TTP and pregnancy

P Gounder et al. Br J Haematol. 2024 Oct.

Abstract

Acute thrombocytopenic purpura (TTP) may present at any stage of pregnancy and the puerperium. Without prompt diagnosis and therapy, serious maternal and fetal outcomes may result. ADAMTS13 replacement via plasma exchange and immunosuppression are the mainstay of treatment. There may be a role, however, for newer therapies, including caplacizumab and recombinant ADAMTS13. Differentiation of immune TTP and congenital TTP is vital, particularly to guide the management of subsequent pregnancies.

Keywords: TTP; pregnancy; treatment.

PubMed Disclaimer

References

REFERENCES

    1. Fakhouri F, Scully M, Provôt F, Blasco M, Coppo P, Noris M, et al. Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group. Blood. 2020;136(19):2103–2117.
    1. Béranger N, Tsatsaris V, Coppo P, Veyradier A, Joly BS. High sFlt‐1 (soluble fms‐like tyrosine kinase 1)/PlGF (placental growth factor) ratio in pregnancy‐onset thrombotic thrombocytopenic purpura. Hypertension. 2023;80(9):e140–e142.
    1. Cuker A, Cataland SR, Coppo P, de la Rubia J, Friedman KD, George JN, et al. Redefining outcomes in immune TTP: an international working group consensus report. Blood. 2021;137(14):1855–1861.
    1. Scully M, Thomas M, Underwood M, Watson H, Langley K, Camilleri RS, et al. Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes. Blood. 2014;124(2):211–219.
    1. Kühne L, Völker LA, Hagmann H, Hägele H, Osterholt T, Eichenauer DA, et al. First use of the anti‐VWF nanobody caplacizumab to treat iTTP in pregnancy. Br J Haematol. 2022;196(3):e30–e33.

MeSH terms

LinkOut - more resources